Yea Christopher

CIK 00016911021 companyFRAMINGHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001691102

Recent Transactions

50 trades

Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Stock Option (Right to Buy)
2026-06-11−27,900→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Stock Option (Right to Buy)
2026-06-11−18,920→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Stock Option (Right to Buy)
2026-06-11−52,600→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Stock Option (Right to Buy)
2026-06-11−53,500→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Stock Option (Right to Buy)
2026-06-11−60,000→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-06-11−229,918→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Stock Option (Right to Buy)
2026-06-11−31,000→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Stock Option (Right to Buy)
2026-06-11−80,000→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Stock Option (Right to Buy)
2026-06-11−20,000→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-06-11−25,000→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-06-11−41,250→ 0 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Employee Stock Option (Right to Buy)
2026-05-27−33,800→ 0 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-05-27$7.07/sh+33,800→ 263,718 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-05-27$26.78/sh−33,800→ 229,918 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-05-26$26.78/sh−1,966→ 229,918 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-05-22$26.78/sh−2,358→ 228,759 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-05-22−3,125→ 25,000 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-05-22+3,125→ 231,884 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-05-21+3,750→ 231,117 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-05-21−3,750→ 41,250 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-05-18$26.76/sh−1,108→ 227,367 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-05-17−1,774→ 0 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-05-17+1,774→ 228,475 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-02-23$15.57/sh−4,347→ 226,701 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-02-22−3,125→ 28,125 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-02-22+3,125→ 231,048 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-02-21−3,750→ 45,000 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-02-21+3,750→ 227,923 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-02-18$15.00/sh−1,109→ 224,173 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-02-17−1,774→ 1,774 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-02-17+1,774→ 225,282 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-24$13.45/sh−4,331→ 223,508 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-22+3,125→ 227,839 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-22−3,125→ 31,250 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-21+3,750→ 224,714 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-21−3,750→ 48,750 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-20$0.00/sh+87,390→ 220,964 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Employee Stock Option (Right to Buy)
2025-11-20−87,390→ 0 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-18$14.48/sh−2,683→ 133,574 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-17+4,205→ 136,257 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-17−2,431→ 0 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-17−1,774→ 3,548 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-08-25$13.42/sh−1,954→ 132,052 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-08-22+3,125→ 134,006 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-08-22−3,125→ 34,375 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-08-22$13.22/sh−2,362→ 130,881 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-08-21−3,750→ 52,500 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-08-21+3,750→ 133,243 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-08-18$13.19/sh−2,649→ 129,493 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-08-17+4,203→ 132,142 total

Companies

KalVista Pharmaceuticals, Inc.
CHIEF DEVELOPMENT OFFICER
$KALV

Recent Filings

Address

C/O KALVISTA PHARMACEUTICALS, INC. 200 CROSSING BOULEVARD

FRAMINGHAM, MA, 01702

View on SEC.gov